Lomustine and Intermediate Dose Cytarabine in Older Patients With AML
NCT00480064
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
360
Enrollment
OTHER
Sponsor class
Conditions
Acute Myeloid Leukemia
Interventions
DRUG:
Lomustine, intermediate dose cytarabine
Sponsor
French Innovative Leukemia Organisation